Month: July 2022

Exploring Brain Function and Amyloid Uptake in High-Risk Groups

Imagine you’re a detective investigating a crime scene. You use your detective skills to uncover clues and piece together the puzzle. Similarly, scientists conducted a pilot study using resting-state-functional magnetic resonance imaging (rs-fMRI) to investigate the link between brain function and amyloid-β (Aβ) uptake in high-risk populations for Alzheimer’s Disease (AD). The participants included individuals […]

Published on July 29, 2022

Cerebrospinal Fluid Protein Sheds Light on Alzheimer’s Disease Progression

Imagine you’re in a maze, trying to find your way out. As you explore, you come across glowing footprints on the ground. These footprints represent a protein called 14-3-3ζ, which has been found to increase in the cerebrospinal fluid (CSF) of people with Alzheimer’s disease (AD). In a recent study, researchers analyzed CSF samples from […]

Published on July 29, 2022

Uncovering the Landscape of Neuroinflammation-Induced Mild Cognitive Impairment

Imagine you’re exploring a vast safari and you stumble upon a hidden treasure map. In this case, the map is a bibliometric analysis of research on neuroinflammation-induced mild cognitive impairment (MCI). MCI is like a bridge between normal aging and dementia, and scientists believe that neuroinflammation in the brain plays a major role in its […]

Published on July 29, 2022